Symptom monitoring and health for women on hormone therapy for breast cancer
Part of Cancer clinical trials.
This trial tests a mobile health program to help women manage symptoms and stay healthy while taking hormone therapy (like tamoxifen or anastrozole) for early-stage breast cancer. It involves using a smartphone app and an electronic pill bottle to track your health and medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You identify as a woman and are 18 or older.
- You have been diagnosed with stage 0, I, II, or III hormone receptor-positive (HR+) breast cancer.
- You started taking a standard oral hormone therapy (tamoxifen, anastrozole, exemestane, or letrozole) within the past 16 weeks.
- You have finished any surgery for breast cancer at least 14 days ago, and if you had chemotherapy, it must have ended at least 14 days ago.
- You can speak and read English, own a cell phone with internet, and can use an electronic pill bottle.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a smartphone app called Sidekick to help women with early-stage breast cancer stick to their hormone therapy and feel more confident managing their health. If you were diagnosed with stage I, II, or III breast cancer after September 2023 and are starting hormone therapy, this program might help you stay on track.
This trial tests whether combining regular medication safety checks with electronic tracking of side effects can improve quality of life and help reduce economic burden for people taking cancer pills. It’s for people starting oral cancer therapy and using connected technology to report symptoms.
This trial tests whether using a smartphone app to report symptoms helps patients feel better and manage side effects during cancer treatment. If you have cancer at any stage and are on systemic therapy, you may be able to join.
This study tests whether a smartphone app (Caaring®) can help monitor cancer patients who take oral medications. If you are on an oral cancer treatment and comfortable using a smartphone, this trial may help you stay connected with your care team and manage side effects from home.
This study tests a system where you report your symptoms online or by phone from home. A nurse will call you to help manage any side effects of your treatment.
This trial tests a digital tool (a smartphone app) to help women and men with early breast cancer manage side effects from hormone therapy. The goal is to improve quality of life during treatment.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.